COMPARISON OF CLINICAL ACTIVITY OF PIMECROLIMUS IN PEDIATRIC PATIENTS WITH MILD AND MODERATE ATOPIC DERMATITIS

E.V. Deeva; L.M. Ogorodova; I.A. Deev; I.V. Sheveleva

COMPARISON OF CLINICAL ACTIVITY OF PIMECROLIMUS IN PEDIATRIC PATIENTS WITH MILD AND MODERATE ATOPIC DERMATITIS

E.V. Deeva, L.M. Ogorodova, I.A. Deev, I.V. Sheveleva

Abstract

Atopic dermatitis (ad) is prevalent disease in younger children. Calcium inhibitor pimecrolimus (elidel, cream 1%) is the latest anti-inflammatory drug offered for management of ad. The activity of pimecrolimus was evaluated in open, prospective, randomized, comparison trial, on 60 children (age from 3 months to 7 years) with mild and moderate ad. Pimecrolimus was more effective in management of mild ad on the assumption of regular use of drug (TIS < 17), and topical corticosteroids were effective in patients with moderate ad.
Key words: children, atopic dermatitis, pimecrolimus, topical corticosteroids, management.

About the Authors

E.V. Deeva

Siberian State Medical University, Tomsk
Russian Federation

L.M. Ogorodova

Siberian State Medical University, Tomsk
Russian Federation

I.A. Deev

Siberian State Medical University, Tomsk
Russian Federation

I.V. Sheveleva

Siberian State Medical University, Tomsk
Russian Federation

References

1. Akdis C.A., Akdis M., Bieber T. et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy. 2006; 61 (8): 969–987.

2. Атопический дерматит и инфекции кожи у детей: диагностика, лечение, профилактика. Научно-практическая программа. Союз педиатров России. М. 2004. С. 52.

3. Бронхиальная астма у детей: диагностика, лечение и профилактика: научно-практическая программа. Союз педиатров России, Международный фонд охраны здоровья матери и ребенка. М. 2004. С. 46.

4. Современная стратегия терапии атопического дерматита: программа действий педиатра. Согласительный документ ассоциации детских аллергологов-иммунологов России. М., 2004. С. 96.

5. Короткий Н.Г., Тихомиров А.А. и др. Атопический дерматит у детей. Тверь: Триада. 2003. С. 34.

6. Hoare C., Williams H., Li Wan Po. Systematic review of treatments for atopic eczema. Health Technol Assess. 2000; 4 (37): 1–187.

7. Jan V., Vaillant L., Bressieux J. et al. ShortBterm cyclosporine monotherapy for chronic severe atopic eczema. Eur. J. Dermatol. 1999; 9 (8): 615–617.

8. Ревякина В.А., Огородова Л.М., Деев И.А. и др. Результаты Национального многоцентрового клинико-эпидемиологического исследования атопического дерматита у детей. Аллергология. 2006; 1: 3–10.

Review

For citations:

Deeva E., Ogorodova L., Deev I., Sheveleva I. COMPARISON OF CLINICAL ACTIVITY OF PIMECROLIMUS IN PEDIATRIC PATIENTS WITH MILD AND MODERATE ATOPIC DERMATITIS. Current Pediatrics. 2008;7(2):55-61.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International.

ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Current Pediatrics

COMPARISON OF CLINICAL ACTIVITY OF PIMECROLIMUS IN PEDIATRIC PATIENTS WITH MILD AND MODERATE ATOPIC DERMATITIS

Abstract

About the Authors

References

Review

For citations:

Cookies policy